Search
Altimmune Inc
ALTAdd to Watchlist
3.040USD
-0.150-4.70%
Close 09-24 16:00（ET）
591.19MMarket Cap
LossP/E TTM
After-hours 19:45 (ET)3.060USD+0.015+0.49%
After-hours 19:45 (ET)About Altimmune Inc Company
Altimmune, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing next-generation peptide-based therapeutics. It is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity, metabolic dysfunction-associated steatohepatitis (MASH) and other indications. Activation of the GLP-1 and glucagon receptors is believed to mimic the complementary effects of diet and exercise on weight loss, with GLP-1 suppressing appetite and glucagon increasing energy expenditure. Glucagon is also recognized as having direct effects on hepatic fat metabolism, to rapid reductions in levels of liver fat and serum lipids. The Company has completed the MOMENTUM Phase II obesity trial and is being studied in the IMPACT Phase IIb MASH trial. The Company also develops and commercializes surfactant-functionalized (EuPort domain) incretin-based peptide therapeutics, including (GLP-1-glucagon)/oxyntomodulin, and variants.
Altimmune Inc Profile
Ticker SymbolALT
Company nameAltimmune Inc
IPO dateOct 06, 2005
CEODurso (Jerome Benedict)
Number of employees59
Security typeOrdinary Share
Fiscal year-endOct 06
Address910 Clopper Road
CityGAITHERSBURG
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code20878-1361
Phone12406541450
Websitehttps://altimmune.com/
Ticker SymbolALT
IPO dateOct 06, 2005
CEODurso (Jerome Benedict)
Company Executives of Altimmune Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Vipin K. Garg, Ph.D.
Dr. Vipin K. Garg, Ph.D.
Director
Director
424.52K
+16.36%
Mr. Raymond M. (Ray) Jordt
Mr. Raymond M. (Ray) Jordt
Chief Business Officer
Chief Business Officer
70.11K
+48.26%
Mr. Jerome Benedict (Jerry) Durso
Mr. Jerome Benedict (Jerry) Durso
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
62.50K
+24.00%
Mr. Jerome Benedict (Jerry) Durso
Mr. Jerome Benedict (Jerry) Durso
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
62.50K
+24.00%
Mr. Jerome Benedict (Jerry) Durso
Mr. Jerome Benedict (Jerry) Durso
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
62.50K
+24.00%
Mr. Gregory L. (Greg) Weaver
Mr. Gregory L. (Greg) Weaver
Chief Financial Officer
Chief Financial Officer
39.83K
+4.40%
Mr. Gregory L. (Greg) Weaver
Mr. Gregory L. (Greg) Weaver
Chief Financial Officer
Chief Financial Officer
39.83K
+4.40%
Mr. Gregory L. (Greg) Weaver
Mr. Gregory L. (Greg) Weaver
Chief Financial Officer
Chief Financial Officer
39.83K
+4.40%
Dr. Mitchel B. (Mitch) Sayare, Ph.D.
Dr. Mitchel B. (Mitch) Sayare, Ph.D.
Independent Director
Independent Director
26.36K
--
Dr. Mitchel B. (Mitch) Sayare, Ph.D.
Dr. Mitchel B. (Mitch) Sayare, Ph.D.
Independent Director
Independent Director
26.36K
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Vipin K. Garg, Ph.D.
Dr. Vipin K. Garg, Ph.D.
Director
Director
424.52K
+16.36%
Mr. Raymond M. (Ray) Jordt
Mr. Raymond M. (Ray) Jordt
Chief Business Officer
Chief Business Officer
70.11K
+48.26%
Mr. Jerome Benedict (Jerry) Durso
Mr. Jerome Benedict (Jerry) Durso
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
62.50K
+24.00%
Mr. Jerome Benedict (Jerry) Durso
Mr. Jerome Benedict (Jerry) Durso
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
62.50K
+24.00%
Mr. Jerome Benedict (Jerry) Durso
Mr. Jerome Benedict (Jerry) Durso
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
62.50K
+24.00%
Mr. Gregory L. (Greg) Weaver
Mr. Gregory L. (Greg) Weaver
Chief Financial Officer
Chief Financial Officer
39.83K
+4.40%
FAQs
Who are the top five shareholders of Altimmune Inc?
The top five shareholders of Altimmune Inc are: Dr. Vipin K. Garg, Ph.D.
How many institutions hold shares of Altimmune Inc (ALT)?
As of 2026Q1, 416 institutions hold shares of Altimmune Inc, with a combined market value of approximately 57.72M, accounting for 30.53% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 4635873.00.